Navigation Links
Perrigo Company Will Release Third Quarter Fiscal 2008 Results on May 6, 2008
Date:4/23/2008

ALLEGAN, Mich., April 23 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it will release financial results for its third quarter fiscal 2008 on Tuesday, May 6, 2008 at approximately 8:00 a.m. (ET). The Company will conduct a conference call at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo's Chairman and Chief Executive Officer.

The conference call will be available live via webcast to interested parties on the Perrigo website http://www.perrigo.com or by phone 888-694-4676, International 973-582-2737, and reference ID# 44342528. A taped replay of the call will be available beginning at approximately 2:30 p.m. (ET) Tuesday, May 6, until midnight Tuesday, May 13, 2008. To listen to the replay, call 800-642-1687, International 706-645-9291, access code 44342528.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).


'/>"/>
SOURCE Perrigo Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Perrigo Confirms Patent Challenge of Monistat(R) 1 Combination Pack
2. Perrigo Company to Present at the 12th Annual Sidoti Emerging Growth Institutional Investor Forum
3. Perrigo Company Announces Launch of Clobetasol Propionate Foam
4. Perrigo Company Receives Final Approval on Clobetasol Propionate Foam
5. Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets
6. Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets
7. Perrigo Company Announces Final FDA Approval for OTC Famotidine Complete Chewable Tablets
8. Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend
9. Perrigo Acquires UK OTC Store Brand Supplier
10. Perrigo Company to Present at The 26th Annual JPMorgan Healthcare Conference
11. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... July 27, 2017 , ... Georgia Urology , ... Dr. Brent Sharpe who is now serving urology patients in the Braselton and ... in Flowery Branch, and is open on Mondays, Tuesdays, Wednesdays, and Fridays. The Gainesville ...
(Date:7/27/2017)... (PRWEB) , ... July 27, 2017 , ... ... a new set of teeth in a single office visit from Dr. Alejandro ... comfortable treatment solutions to his East Texas patients, including Teeth-in-a-Day® dental implants ...
(Date:7/27/2017)... Santa Clara, CA (PRWEB) , ... July 27, ... ... technology, announces the addition of a secure cloud-based polysomnography (PSG) distributed scoring solution ... to support accelerated diagnostics and sleep care management. The speed and functionality of ...
(Date:7/27/2017)... ... ... Los Angeles leg of the US movie premier of the Man in the Camo Jacket ... Clive Davis Theater inside the Grammy Museum Located in downtown Los Angeles in the LA ... rock musician, Mike Peters (of The Alarm), his rise to fame, battle with cancer and ...
(Date:7/27/2017)... ... 2017 , ... Team Novo Nordisk, the world’s first all-diabetes professional cycling team, ... a stagiaire for the remainder of the 2017 season. One of our best development ... Tour of Utah. , “Every season we are excited to move an athlete from ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... -- Eli Lilly and Company (NYSE: LLY ) has ... pending patent litigation in the U.S. District Court for the ... Cialis ® (tadalafil) unit dose patent. This patent was ... of the agreement, Cialis exclusivity is now expected to end ... unit dose patent for Cialis is valid and infringed by ...
(Date:7/11/2017)... 11, 2017  Sysmex America, Inc., a leading ... equipment as well as middleware information systems technology, ... make quality assurance easier and more risk free ... known for the innovation that it delivers to ... quality assurance processes to a new level with ...
(Date:7/10/2017)... July 10, 2017 The Institute for In ... is the recipient of a VITROCELL® inhalation exposure system ... Science Consortium. The device, which is designed to replace ... human lung cells to airborne test materials in an ... the VITROCELL® system for testing combustible tobacco products, as ...
Breaking Medicine Technology: